ZITHROMAX FOR INTRAVENOUS INJECTION
ZITHROMAX FOR INTRAVENOUS INJECTION
Approved
DIN Number
02239952
Drug Class
Human
Market Date
Aug 27, 1999
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02239952
AIG Number0126072006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01FA10 AZITHROMYCIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification08:12.12.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
AZITHROMYCINActive
Strength: 500 MG / VIAL
Monograph: AZITHROMYCIN